Article
Inhibition of CYP2D6 activity by treatment with propranolol and the role of 4-hydroxy propranolol.
British journal of clinical pharmacology - 1 Jul 1994
Rowland K, Yeo W W, Ellis S W, Chadwick I G, Haq I, Lennard M S, Jackson P R, Ramsay L E, Tucker G T
Abstract excerpt
1. The 4-hydroxylation of propranolol by rat and human liver microsomes is associated with formation of a chemically reactive species which binds irreversibly to cytochrome P4502D6 (CYP2D6) destroying its catalytic function. Therefore, the effect of propranolol treatment (80 mg twice daily) on debrisoquine phenotype was examined, to see if it resulted in phenocopying in vivo. The role of 4-hydroxypropranolol...
Topics
- Adult
- Aged
- Chromatography, High Pressure Liquid
- Cytochrome P-450 CYP2D6
- Cytochrome P-450 Enzyme Inhibitors
- Cytochrome P-450 Enzyme System
- Debrisoquin
- Female
- Humans
- Male
- Metoprolol
